The Effect of Patient Discharge From the Maternal and Fetal Medicine Unit With Receiving a Discharge Letter Later Using the Apollo App on Discharge Data, Safety and Patient Satisfaction

NCT ID: NCT06604559

Last Updated: 2024-09-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

140 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-11-30

Study Completion Date

2025-09-05

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Women admitted to the maternal and fetal medicine unit are often discharged after a short hospital stay. The routine work in the department is prioritized such that the discharge letter are written. In the last year the Apollo mobile application (app) was introduced. It contains general information on the medical center and the maternal and fetal unit department as well as the medical records, laboratory results and summary and discharge letters. The Apollo app is used in the maternal and fetal unit in the discharge process so the patient can receive the discharge letter in the app and does not need to wait until the discharge letter is written.

It is not known whether this process is more effective than the regular discharge process and patients' satisfaction was not assessed previously.

In the present study we will compare discharge data, satisfaction and safety of discharging using the Apollo app versus the routine process.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Patient Satisfaction Health Care Utilization

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Application discharge

The discharge is conditional on the approval of a senior physician or the attending physician in charge. The participant will sign on a "Form for discharge and consent to receive a discharge letter, using the "Apollo" application" in which the discharge process, recommendations and contact information of the department are described. Thereafter, the patient will be discharge home and the discharge letter will be available in the app once it is written. The participant is guided to contact the department, in case the discharge letter is not received in the application up to 24 hours after discharge.

Group Type EXPERIMENTAL

Discharge using Apollo application

Intervention Type OTHER

Discharge using Apollo application

Regular discharge

The discharge is conditional on the approval of a senior physician or the attending physician in charge. The patient will go home only after the discharge letter is written.

Group Type OTHER

Regular discharge

Intervention Type OTHER

Discharge with the regular process

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Discharge using Apollo application

Discharge using Apollo application

Intervention Type OTHER

Regular discharge

Discharge with the regular process

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Women who are admitted to the maternal and fetal medicine unit with the intention to be discharged before delivery
* 18 years old and older
* Consent to participate
* Owner of a smart phone
* Consent to download the Apollo app

Exclusion Criteria

* Delivery during her admission
* Doesn't own a smart phone
* Refusal to download to Apollo app
* Refusal to participate
Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

The Baruch Padeh Medical Center, Poriya

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Tzafon Medical center, Poriya

Tiberias, North, Israel

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Israel

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Enav Yefet

Role: CONTACT

972-46652306

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Enav Yefet, MD/PhD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

55-24-POR

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.